MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.med.2022.10.015

Медицинская библиотека · Medicine · 2022

[Treatment protocol for manifestations of persistent COVID].

Noval A Roca, Miravalls J Díaz, García R García

Аннотация на английскомСтатьяПеревод в очереди

Аннотация

Persistent COVID is a symptomatic disease involving multiple organs which affects patients who have had COVID-19 and who continue to have symptoms (asthenia, arthralgia, myalgia, headache, dyspnea, cough, chest pain, dysphonia) for more than 4-12 weeks after infection. Its presentation is independent of the severity of the acute COVID-19 phase. It is predominant in middle-aged women. Symptoms frequently fluctuate. It can progress in the form of flare-ups and cannot be explained by an alternative underlying pathology. The incidence of persistent COVID is estimated to be about 10% of those infected. In addition to this symptomatic disease, it is possible that survivors of COVID-19 pneumonia may present with lung sequelae. It is probable that a high number of patients who have had COVID-19 pneumonia will require specialized follow-up by the pulmonology department after overcoming the acute phase. Different algorithms are being established to ensure proper follow-up for these patients.

Для цитирования: Noval A Roca, Miravalls J Díaz, García R García. [Treatment protocol for manifestations of persistent COVID].. Medicine. 2022. DOI: 10.1016/j.med.2022.10.015.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.